+44 (0) 1223 755950
+1 832 327 7413
orders@abbexa.com
Click on the image to see the image legend
Target | Breast Cancer Type 1 Susceptibility Protein Phospho-Ser1457 (BRCA1 pS1457) |
Clonality | Polyclonal |
Target Modification | Ser1457 |
Modification | Phosphorylation |
Reactivity | Human |
Tested Applications | ELISA, WB |
Host | Rabbit |
Recommended dilutions | WB: 1/500 - 1/3000, ELISA: 1/1000. Optimal dilutions/concentrations should be determined by the end user. |
Conjugation | Unconjugated |
Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human BRCA1 around the phosphorylation site of serine 1457 (L-T-SP-Q-K). |
Isotype | IgG |
Form | Liquid |
Purification | Purified from rabbit antiserum by affinity chromatography using epitope-specific immunogen. |
Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
UniProt Primary AC | P38398 (UniProt, ExPASy) |
UniProt Secondary AC | E9PFZ0, O15129, Q1RMC1, Q3LRJ0, Q3LRJ6, Q6IN79, Q7KYU9 |
UniProt Entry Name | BRCA1_HUMAN |
KEGG | hsa:672 |
String | 9606.ENSP00000418960 |
Buffer | PBS (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02% sodium azide, 50% glycerol. |
Concentration | 1 mg/ml |
Availability | Shipped within 5-10 working days. |
Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. |